Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 1;137(13):1719-1730.
doi: 10.1182/blood.2020005477.

Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease

Isabel C Yoon  1 , Nicholas A Bascou  1 , Michele D Poe  1 , Paul Szabolcs  1 , Maria L Escolar  1
Affiliations

Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease

Isabel C Yoon et al. Blood. .

Abstract

Krabbe disease is a rare neurodegenerative disorder caused by a deficiency in galactocerebrosidase. The only effective treatment is hematopoietic stem cell transplantation (HSCT). Approximately 85% of Krabbe disease cases are the infantile subtypes, among which ∼20% are late infantile. Prior studies have demonstrated that HSCT is effective for early-infantile patients (0-6 months of age) who undergo transplantation while asymptomatic, compared with those receiving transplants while symptomatic. However, no studies evaluated the efficacy of HSCT for late-infantile patients (6-36 months). In this prospective, longitudinal study, patients were evaluated at a single site according to a standardized protocol. Survival analysis was performed using the Kaplan-Meier method. Differences between groups were estimated using mixed regression models to account for within-person repeated measures. Nineteen late-infantile patients underwent HSCT (March 1997 to January 2020). Compared with untreated patients, transplant recipients had a longer survival probability and improved cognitive and language function. Gross and fine motor development were most affected, with variable results. Asymptomatic patients benefitted the most from transplantation, with normal to near-normal development in all domains and some gross motor delays. Among symptomatic patients, those with disease onset at >12 months of age had better cognitive outcomes than untreated patients. Those with disease onset at ≤12 months were comparable to untreated patients. We found that HSCT prolonged the lifespan and improved the functional abilities of late-infantile patients with Krabbe disease, particularly those who underwent transplantation before onset of symptoms. In addition, our findings support prior literature that reclassifies late-infantile Krabbe disease to be symptom onset at 12 to 36 months of age.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest-disclosure: M.L.E. and P.S. have financial interest in Forge Biologics, and M.L.E. is a part-time employee. The remaining authors declare no competing financial interests.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Kaplan-Meier curves for overall survival.
Figure 2.
Figure 2.
Psychosine levels at various ages in the patients with data available. Each line represents a single patient, and each circle indicates an individual measurement.
Figure 3.
Figure 3.
Height, weight, and head circumference of the patients. Each line represents a patient, and each circle indicates an individual measurement. The gray lines show the standard growth curves for the 3rd, 5th, 10th, 25th, 50th, 75th, 90th, 95th, and 99th percentiles. In the graphs on the left (A-C), blue lines indicate boys, and in the graphs on the right (D-F), red lines indicate the girls.
Figure 4.
Figure 4.
Neurodevelopmental outcomes of transplant recipients. Neurodevelopmental domains shown are cognitive development (A), adaptive behavior (B), receptive language (C), expressive language (D), gross motor (E), and fine motor (F). The developmental ages were determined by age-equivalent scores from tests. Each line represents a patient and each circle indicates an individual measurement. Gray lines and areas indicate normal development at the 95th, 50th, and fifth percentiles.
See this image and copyright information in PMC

References

    1. Bascou N, DeRenzo A, Poe MD, Escolar ML. A prospective natural history study of Krabbe disease in a patient cohort with onset between 6 months and 3 years of life. Orphanet J Rare Dis. 2018;13(1):126. - PMC - PubMed
    1. Wenger DA, Rafi MA, Luzi P. Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum Mutat. 1997;10(4):268-279. - PubMed
    1. Chuang WL, Pacheco J, Zhang XK, et al. . Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease. Clin Chim Acta. 2013;419:73-76. - PubMed
    1. Orsini JJ, Escolar ML, Wasserstein MP, Caggana M. Krabbe Disease. In: Adam MP Ardinger HH, Pagon RA, et al., eds. GeneReviews. Seattle, WA: University of Washington; 2000. Updated 11 Oct 2018. Available at: https://www.ncbi.nlm.nih.gov/books/NBK1238/. Accessed 11 August 2020.
    1. Duffner PK, Barczykowski A, Jalal K, Yan L, Kay DM, Carter RL. Early infantile Krabbe disease: results of the World-Wide Krabbe Registry. Pediatr Neurol. 2011;45(3):141-148. - PubMed

Publication types